Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noemi Puig

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Cancers|May 14, 2025
Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre ExperienceElena Alejo, Cristina Agulló, Borja Puertas, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2019
Distribution of subsets of blood monocytic cells throughout lifeDaniela Damasceno, Cristina Teodosio, Wouter B L van den Bossche, et al.
Cancers|April 3, 2021
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaDaniela Damasceno, Julia Almeida, Cristina Teodosio, et al.
Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.
European Journal of Haematology|January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data AnalysisNoemi Puig, Xavier Leleu, Hans C Lee, et al.
Annals of Hematology|August 10, 2012
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survivalCarlos Santamaría, Fernando Ramos, Noemi Puig, et al.
Cancers|March 11, 2023
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple MyelomaBorja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, et al.
Blood Cancer Journal|February 17, 2021
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosisGiovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, et al.
Hematological Oncology|September 9, 2016
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism arrayRamón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, et al.
Hemasphere|December 16, 2024
Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patientsCristina De Ramón, Elizabeta A Rojas, Irena Misiewicz-Krzeminska, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Cancers|May 14, 2025
Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre ExperienceElena Alejo, Cristina Agulló, Borja Puertas, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2019
Distribution of subsets of blood monocytic cells throughout lifeDaniela Damasceno, Cristina Teodosio, Wouter B L van den Bossche, et al.
Cancers|April 3, 2021
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaDaniela Damasceno, Julia Almeida, Cristina Teodosio, et al.
Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.
European Journal of Haematology|January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data AnalysisNoemi Puig, Xavier Leleu, Hans C Lee, et al.
Annals of Hematology|August 10, 2012
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survivalCarlos Santamaría, Fernando Ramos, Noemi Puig, et al.
Cancers|March 11, 2023
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple MyelomaBorja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, et al.
Blood Cancer Journal|February 17, 2021
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosisGiovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, et al.
Hematological Oncology|September 9, 2016
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism arrayRamón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, et al.
Hemasphere|December 16, 2024
Expression profile of Bcl-2 family proteins in newly diagnosed multiple myeloma patientsCristina De Ramón, Elizabeta A Rojas, Irena Misiewicz-Krzeminska, et al.
Pageof 9